Abstract
ABSTRACT: Human Lactobacillus sp strain GG (Lactobacillus GG) administered during acute rotavirus diarrhea has been shown to promote clinical recovery. To elucidate the immune mechanisms behind such a favorable outcome, the ELISPOT (solid phase enzyme-linked immunospot) assay of Ig- and specific antibody-secreting cells among circulating lymphocytes was used, giving indirect evidence of the immunologic events in the gut. After rehydration, 39 children with acute rotavirus diarrhea, mean age 16 (SD 6) mo, randomly received either a Lactobacillus GG fermented milk product (study group) or a pasteurized yogurt (placebo group). The duration of diarrhea was significantly shorter in the study group than in the placebo group [mean 1.1 (SD 0.6) versus 2.5 (SD 1.4) d, p = 0.001]. Lactobacillus GG therapy was associated with a significantly enhanced nonspecific humoral response during the acute phase of the infection, reflected in the IgG, IgA, and IgM Ig-secreting cell numbers. At convalescence, 90% of the study group versus 46% of the placebo group had developed an IgA specific antibody-secreting cell response to rotavirus (p = 0.006). The results indicate that Lactobacillus GG promotes recovery from rotavirus diarrhea via augmentation of the local immune defense. Furthermore, specific IgA response to rotavirus is endorsed, which is possibly relevant in protection against reinfections.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kaila, M., Isolauri, E., Soppi, E. et al. Enhancement of the Circulating Antibody Secreting Cell Response in Human Diarrhea by a Human Lactobacillus Strain. Pediatr Res 32, 141–144 (1992). https://doi.org/10.1203/00006450-199208000-00002
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199208000-00002
This article is cited by
-
Lacticaseibacillus casei T1 attenuates Helicobacter pylori-induced inflammation and gut microbiota disorders in mice
BMC Microbiology (2023)
-
Is there a role for microbiome-based approach in common variable immunodeficiency?
Clinical and Experimental Medicine (2023)
-
Profiles of gut microbiota in obese-insulin-resistant rats treated with biotics
European Journal of Nutrition (2022)
-
Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics
Applied Microbiology and Biotechnology (2022)
-
Analysis of the intestinal microbial community altered during rotavirus infection in suckling mice
Virology Journal (2021)